cases from the literature were (re-)classified according to ICD-O-3, as seemed appropriate according to the available information.
| | ICD-O code or range | Code translation | Cases |
 | 0000/0 | not classified in ICD-O 3 [e.g. non-neoplastic or benign] | 305 |
 | 8000/3 | Neoplasm, malignant | 3 |
 | 8010/2 | Carcinoma in situ, NOS | 10 |
 | 8010/3 | Carcinoma, NOS | 85 |
 | 8012/3 | Large cell carcinoma, NOS | 21 |
 | 8013/3 | Large cell neuroendocrine carcinoma | 20 |
 | 8020/3 | Carcinoma, undifferentiated type, NOS | 3 |
 | 8021/3 | Carcinoma, anaplastic type, NOS | 39 |
 | 8022/3 | Pleomorphic carcinoma | 1 |
 | 8032/3 | Spindle cell carcinoma | 1 |
 | 8033/3 | Sarcomatoid carcinoma | 4 |
 | 8041/3 | Small cell carcinoma, NOS | 70 |
 | 8046/3 | Non-small cell carcinoma | 6 |
 | 8050/3 | Papillary carcinoma, NOS | 2 |
 | 8052/0 | Squamous cell papilloma | 132 |
 | 8070/1 | Premalignant squamous epithelium, NOS | 162 |
 | 8070/2 | Squamous cell carcinoma in situ, NOS | 16 |
 | 8070/3 | Squamous cell carcinoma, NOS | 1506 |
 | 8071/0 | Squamous cell keratosis, NOS | 12 |
 | 8075/3 | Squamous cell carcinoma, acantholytic | 2 |
 | 8077/2 | Squamous intraepithelial neoplasia, grade III | 22 |
 | 8090/3 | Basal cell carcinoma, NOS | 15 |
 | 8120/2 | Transitional cell carcinoma in situ | 10 |
 | 8120/3 | Transitional cell carcinoma, NOS | 251 |
 | 8130/1 | Urothelial papilloma, NOS | 1 |
 | 8130/2 | Papillary transitional cell carcinoma, non-invasive | 56 |
 | 8130/3 | Papillary transitional cell carcinoma | 7 |
 | 8140/0 | Adenoma, NOS | 319 |
 | 8140/1 | atypical adenoma | 10 |
 | 8140/2 | Adenocarcinoma in situ | 11 |
 | 8140/3 | Adenocarcinoma, NOS | 2169 |
 | 8144/3 | Adenocarcinoma, intestinal type | 197 |
 | 8145/3 | Carcinoma, diffuse type | 8 |
 | 8148/2 | Glandular intraepithelial neoplasia, grade III | 15 |
 | 8150/1 | Islet cell adenoma | 8 |
 | 8150/3 | Islet cell carcinoma | 18 |
 | 8151/1 | Insulinoma, NOS | 28 |
 | 8151/3 | Insulinoma, malignant | 7 |
 | 8152/1 | Glucagonoma, NOS | 5 |
 | 8152/3 | Glucagonoma, malignant | 8 |
 | 8153/1 | Gastrinoma, NOS | 3 |
 | 8153/3 | Gastrinoma, malignant | 5 |
 | 8155/3 | Vipoma | 8 |
 | 8156/1 | Somatostatinoma, NOS | 11 |
 | 8160/3 | Cholangiocarcinoma | 78 |
 | 8170/0 | Hepatocellular adenoma, NOS | 29 |
 | 8170/3 | Hepatocellular carcinoma, NOS | 559 |
 | 8171/3 | Hepatocellular carcinoma, fibrolamellar | 10 |
 | 8200/3 | Adenoid cystic carcinoma | 55 |
 | 8201/3 | Ductal carcinoma, cribriform type [C50._] | 2 |
 | 8211/3 | Tubular adenocarcinoma | 5 |
 | 8240/3 | Carcinoid tumor, NOS | 41 |
 | 8246/3 | Neuroendocrine carcinoma | 71 |
 | 8247/3 | Merkel cell carcinoma | 71 |
 | 8249/3 | Atypical carcinoid tumor | 6 |
 | 8250/3 | Bronchiolo-alveolar adenocarcinoma | 2 |
 | 8260/3 | Papillary adenocarcinoma, NOS | 199 |
 | 8271/0 | Prolactinoma | 13 |
 | 8272/0 | Pituitary adenoma, typical | 47 |
 | 8272/3 | Pituitary carcinoma, NOS | 4 |
 | 8290/0 | Oncocytoma | 76 |
 | 8290/3 | Follicular carcinoma, oxyphilic cell | 19 |
 | 8310/3 | Clear cell renal cell carcinoma | 59 |
 | 8312/3 | Renal cell carcinoma | 309 |
 | 8317/3 | Renal cell carcinoma, chromophobe | 21 |
 | 8319/3 | Renal medullary carcinoma | 9 |
 | 8330/0 | Follicular adenoma, NOS | 16 |
 | 8330/3 | Follicular adenocarcinoma, NOS | 27 |
 | 8333/0 | Fetal adenoma | 10 |
 | 8335/3 | Follicular carcinoma | 20 |
 | 8337/3 | Insular carcinoma | 1 |
 | 8340/3 | Papillary carcinoma, follicular variant | 8 |
 | 8342/3 | Papillary carcinoma, oxyphilic cell | 1 |
 | 8361/0 | Juxtaglomerular tumor [C64.9] | 2 |
 | 8370/3 | Adrenal cortical carcinoma | 50 |
 | 8380/1 | Endometrioid dysplasia | 37 |
 | 8380/3 | Endometrioid carcinoma, NOS | 63 |
 | 8384/3 | Adenocarcinoma, endocervical type | 14 |
 | 8401/2 | Apocrine DCIS | 10 |
 | 8401/3 | Apocrine adenocarcinoma | 4 |
 | 8430/3 | Mucoepidermoid Carcinoma | 2 |
 | 8441/3 | Serous carcinoma, NOS | 111 |
 | 8442/1 | Serous cystadenoma, borderline malignancy | 21 |
 | 8450/3 | Papillary cystadenocarcinoma, NOS | 2 |
 | 8460/3 | Papillary serous cystadenocarcinoma | 123 |
 | 8461/3 | Serous surface papillary carcinoma | 11 |
 | 8470/3 | Mucinous cystadenocarcinoma, NOS | 19 |
 | 8472/1 | Mucinous cystic tumor of borderline malignancy | 13 |
 | 8480/3 | Mucinous adenocarcinoma | 52 |
 | 8481/3 | Mucin-producing adenocarcinoma | 9 |
 | 8490/3 | Signet ring cell carcinoma | 30 |
 | 8500/2 | Ductal carcinoma in situ, NOS | 41 |
 | 8500/3 | Infiltrating duct carcinoma, NOS | 916 |
 | 8501/3 | Comedocarcinoma, NOS | 11 |
 | 8503/2 | Noninfiltrating intraductal papillary adenocarcinoma | 1 |
 | 8503/3 | Intraductal papillary adenocarcinoma with invasion | 2 |
 | 8507/2 | Intraductal micropapillary carcinoma | 16 |
 | 8510/3 | Medullary carcinoma, NOS | 90 |
 | 8520/3 | Invasive lobular carcinoma | 64 |
 | 8522/3 | Infiltrating duct and lobular carcinoma | 1 |
 | 8523/3 | Infiltrating duct mixed with other types of carcinoma [C50._] | 4 |
 | 8550/3 | Acinar cell carcinoma | 6 |
 | 8560/3 | Adenosquamous carcinoma | 4 |
 | 8562/3 | Myoepithelial carcinoma | 10 |
 | 8576/3 | Hepatoid adenocarcinoma | 3 |
 | 8581/3 | Thymoma, medullary [WHO A], malignant | 12 |
 | 8585/3 | Thymoma, atypical [WHO B3], malignant | 17 |
 | 8586/3 | Thymoma, type C [C37.9] | 10 |
 | 8620/3 | Granulosa cell tumor, malignant | 56 |
 | 8640/3 | Sertoli cell carcinoma | 1 |
 | 8680/1 | Paraganglioma, NOS | 3 |
 | 8682/1 | Parasympathetic paraganglioma | 16 |
 | 8693/3 | Extra-adrenal paraganglioma, malignant | 8 |
 | 8700/0 | Pheochromocytoma, NOS | 79 |
 | 8700/3 | Pheochromocytoma, malignant | 14 |
 | 8720/0 | Pigmented nevus, NOS | 76 |
 | 8720/3 | Malignant melanoma, NOS | 178 |
 | 8721/3 | Nodular melanoma | 9 |
 | 8727/0 | Dysplastic nevus | 1 |
 | 8742/3 | Lentigo maligna melanoma | 21 |
 | 8744/3 | Acral lentiginous melanoma, malignant | 23 |
 | 8761/3 | Malignant melanoma in congenital melanocytic nevus | 7 |
 | 8770/0 | Epithelioid and spindle cell nevus | 29 |
 | 8770/3 | Mixed epithelial and spindle cell melanoma | 2 |
 | 8780/3 | Blue nevus, malignant | 5 |
 | 8800/3 | Sarcoma, NOS | 25 |
 | 8804/3 | Epithelioid sarcoma | 2 |
 | 8805/3 | Undifferentiated sarcoma | 1 |
 | 8810/0 | Fibroma, NOS | 3 |
 | 8810/3 | Fibrosarcoma, NOS | 59 |
 | 8811/0 | Fibromyxoid tumor, NOS | 1 |
 | 8811/3 | Myxoinflammatory fibroblastic sarcoma | 6 |
 | 8815/0 | Solitary fibrous tumor | 13 |
 | 8815/3 | Solitary fibrous tumor, malignant | 4 |
 | 8820/0 | Elastofibroma | 27 |
 | 8821/1 | Desmoid-type fibromatosis | 30 |
 | 8823/0 | Desmoplastic fibroma | 12 |
 | 8825/0 | Myofibroblastic tumor, NOS | 1 |
 | 8830/3 | Fibrous histiocytoma, malignant | 188 |
 | 8850/0 | Lipoma, NOS | 27 |
 | 8850/3 | Liposarcoma, NOS | 24 |
 | 8851/3 | Liposarcoma, well differentiated | 55 |
 | 8852/3 | Liposarcoma, myxoid | 13 |
 | 8854/3 | Liposarcoma, pleomorphic | 18 |
 | 8855/3 | Mixed type liposarcoma | 13 |
 | 8858/3 | Liposarcoma, dedifferentiated | 13 |
 | 8890/0 | Leiomyoma, NOS | 28 |
 | 8890/3 | Leiomyosarcoma, NOS | 195 |
 | 8891/3 | Epithelioid leiomyosarcoma | 1 |
 | 8894/0 | Angioleiomyoma | 2 |
 | 8895/3 | Myosarcoma | 2 |
 | 8900/3 | Rhabdomyosarcoma, NOS | 17 |
 | 8901/3 | Rhabdomyosarcoma, pleomorphic | 7 |
 | 8920/3 | Alveolar rhabdomyosarcoma | 1 |
 | 8930/3 | Endometrial stromal sarcoma | 3 |
 | 8931/3 | Endometrial stromal sarcoma, low grade | 9 |
 | 8936/0 | Gastrointestinal stromal tumor, benign | 102 |
 | 8936/1 | Gastrointestinal stromal tumor, uncertain malignant potential | 112 |
 | 8936/3 | Gastrointestinal stromal tumor, malignant | 260 |
 | 8950/3 | Mullerian mixed tumor | 1 |
 | 8951/3 | Mesodermal mixed tumor | 1 |
 | 8960/3 | Nephroblastoma, NOS | 217 |
 | 8964/3 | Clear cell sarcoma of kidney | 31 |
 | 8970/3 | Hepatoblastoma | 127 |
 | 8971/3 | Pancreatoblastoma | 1 |
 | 8973/3 | Pleuropulmonary blastoma | 5 |
 | 8980/3 | Carcinosarcoma, NOS | 23 |
 | 8982/0 | Myoepithelioma | 13 |
 | 8982/3 | Malignant myoepithelioma | 19 |
 | 8990/3 | Mesenchymoma, malignant | 1 |
 | 8991/3 | Embryonal sarcoma | 8 |
 | 9010/0 | Fibroadenoma, NOS | 28 |
 | 9020/0 | Phyllodes tumor, benign | 37 |
 | 9020/1 | Phyllodes tumor, borderline | 17 |
 | 9020/3 | Phyllodes tumor, malignant | 22 |
 | 9040/3 | Synovial sarcoma, NOS | 42 |
 | 9041/3 | Synovial sarcoma, monophasic | 75 |
 | 9043/3 | Synovial sarcoma, biphasic | 29 |
 | 9050/3 | Mesothelioma, NOS | 82 |
 | 9051/3 | Desmoplastic mesothelioma | 59 |
 | 9052/3 | Epithelioid mesothelioma, malignant | 64 |
 | 9053/3 | Mesothelioma, biphasic, malignant | 27 |
 | 9060/3 | Dysgerminoma | 17 |
 | 9061/3 | Seminoma, NOS | 29 |
 | 9063/3 | Spermatocytic seminoma | 12 |
 | 9064/3 | Germinoma | 7 |
 | 9070/3 | Embryonal carcinoma, NOS | 8 |
 | 9071/3 | Yolk sac tumor | 21 |
 | 9080/0 | Teratoma, benign | 22 |
 | 9080/3 | Teratoma, malignant, NOS | 41 |
 | 9081/3 | Teratocarcinoma | 2 |
 | 9085/3 | Mixed germ cell tumor | 19 |
 | 9100/0 | Hydatidiform mole | 7 |
 | 9100/3 | Choriocarcinoma | 17 |
 | 9101/3 | Choriocarcinoma combined w/ other germ cell elements | 2 |
 | 9104/3 | Malignant placental site trophoblastic tumor | 2 |
 | 9120/0 | Hemangioma, NOS | 10 |
 | 9120/3 | Angiosarcoma | 10 |
 | 9133/3 | Epithelioid hemangioendothelioma, malignant | 1 |
 | 9140/3 | Kaposi sarcoma | 1 |
 | 9150/1 | Hemangiopericytoma, NOS | 12 |
 | 9160/0 | Angiofibroma, NOS | 54 |
 | 9161/1 | Hemangioblastoma | 45 |
 | 9180/3 | Osteosarcoma, NOS | 133 |
 | 9182/3 | Fibroblastic osteosarcoma | 3 |
 | 9183/3 | Osteosarcoma, telangiectatic | 1 |
 | 9186/3 | Central osteosarcoma | 10 |
 | 9220/3 | Chondrosarcoma, NOS | 79 |
 | 9260/3 | Ewing sarcoma | 97 |
 | 9270/3 | Odontogenic tumor, malignant | 2 |
 | 9310/3 | Ameloblastoma, malignant | 29 |
 | 9361/1 | Pineocytoma | 3 |
 | 9362/3 | Pineal parenchymal tumor of intermediate differentiation | 6 |
 | 9370/3 | Chordoma, NOS | 22 |
 | 9380/3 | Glioma, NOS | 8 |
 | 9381/3 | Gliomatosis cerebri | 22 |
 | 9382/3 | Anaplastic oligoastrocytoma | 77 |
 | 9390/1 | Choroid plexus papilloma, NOS | 41 |
 | 9390/3 | Choroid plexus papilloma, malignant | 15 |
 | 9391/3 | Ependymoma, NOS | 209 |
 | 9392/3 | Ependymoma, anaplastic | 53 |
 | 9394/1 | Myxopapillary ependymoma | 22 |
 | 9400/3 | Astrocytoma, NOS | 84 |
 | 9401/3 | Astrocytoma, anaplastic | 55 |
 | 9412/1 | Desmoplastic infantile astrocytoma-ganglioglioma | 3 |
 | 9421/1 | Astrocytoma, juvenile | 11 |
 | 9424/3 | Pleomorphic xanthoastrocytoma | 50 |
 | 9430/3 | Astroblastoma | 7 |
 | 9440/3 | Glioblastoma, NOS | 420 |
 | 9442/3 | Gliosarcoma | 23 |
 | 9450/3 | Oligodendroglioma, NOS | 53 |
 | 9451/3 | Oligodendroglioma, anaplastic | 42 |
 | 9470/3 | Medulloblastoma, NOS | 208 |
 | 9471/3 | Desmoplastic medulloblastoma | 46 |
 | 9472/3 | Medullomyoblastoma | 1 |
 | 9473/3 | Primitive neuroectodermal tumor, NOS | 45 |
 | 9474/3 | Large cell medulloblastoma | 21 |
 | 9490/0 | Ganglioneuroma | 1 |
 | 9490/3 | Ganglioneuroblastoma | 8 |
 | 9500/3 | Neuroblastoma, NOS | 507 |
 | 9503/3 | Neuroepithelioma, NOS | 1 |
 | 9505/1 | Ganglioglioma | 62 |
 | 9506/1 | Neurocytoma | 10 |
 | 9510/3 | Retinoblastoma, NOS | 135 |
 | 9522/3 | Olfactory neuroblastoma | 17 |
 | 9530/0 | Meningioma, NOS | 92 |
 | 9530/3 | Meningioma, malignant | 60 |
 | 9532/3 | Fibrous meningioma, malignant | 2 |
 | 9535/3 | Hemangioblastic meningioma, malignant | 10 |
 | 9540/0 | Neurofibroma, NOS | 64 |
 | 9540/3 | Malignant peripheral nerve sheath tumor | 70 |
 | 9560/0 | Schwannoma, NOS | 61 |
 | 9581/3 | Alveolar soft part sarcoma | 14 |
 | 9582/0 | Granular cell tumor | 7 |
 | 9590/3 | Malignant lymphoma, NOS | 32 |
 | 9591/3 | Malignant lymphoma, B-cell NOS | 5 |
 | 9650/3 | Hodgkin lymphoma, NOS | 27 |
 | 9651/3 | Classical Hodgkin lymphoma, lymphocyte-rich | 8 |
 | 9652/3 | Classical Hodgkin lymphoma, mixed cellularity, NOS | 21 |
 | 9653/3 | Classical Hodgkin lymphoma, lymphocyte depletion, NOS | 2 |
 | 9659/3 | Hodgkin lymphoma, nodular lymphocyte predominance | 19 |
 | 9663/3 | Classical Hodgkin lymphoma, nodular sclerosis, NOS | 19 |
 | 9673/3 | Mantle cell lymphoma | 338 |
 | 9678/3 | Primary effusion lymphoma | 11 |
 | 9679/3 | Mediastinal large B-cell lymphoma | 89 |
 | 9680/3 | Diffuse large B-cell lymphoma, NOS | 740 |
 | 9684/3 | ML, large B-cell, diffuse, immunoblastic, NOS | 16 |
 | 9687/3 | Burkitt lymphoma, NOS | 83 |
 | 9689/3 | Splenic marginal zone lymphoma, NOS | 65 |
 | 9690/3 | Follicular lymphoma, NOS | 270 |
 | 9691/3 | Follicular lymphoma, grade 2 | 63 |
 | 9695/3 | Follicular lymphoma, grade 1 | 47 |
 | 9698/3 | Follicular lymphoma, grade 3 | 14 |
 | 9699/3 | Marginal zone lymphoma, NOS | 116 |
 | 9700/3 | Mycosis fungoides | 152 |
 | 9701/3 | Sezary syndrome | 255 |
 | 9702/3 | Malignant lymphoma, T-cell NOS | 46 |
 | 9705/3 | Peripheral T-cell lymphoma, NOS | 62 |
 | 9709/3 | Malignant lymphoma, T-cell NOS, cutaneous | 9 |
 | 9714/3 | Anaplastic large cell lymphoma, NOS | 105 |
 | 9716/3 | Hepatosplenic gamma/delta T-cell lymphoma | 2 |
 | 9717/3 | Enteropathy type T-cell lymphoma | 71 |
 | 9718/3 | Anaplastic large cell lymphoma, cutaneous type | 59 |
 | 9719/3 | NK/T-cell lymphoma | 24 |
 | 9727/3 | Precursor cell lymphoblastic lymphoma, NOS | 1 |
 | 9728/3 | Precursor B-cell lymphoblastic lymphoma | 2 |
 | 9729/3 | Precursor T-cell lymphoblastic lymphoma | 1 |
 | 9731/3 | Plasmacytoma, NOS | 54 |
 | 9732/3 | Plasma cell myeloma | 253 |
 | 9733/3 | Plasma cell leukemia | 15 |
 | 9734/3 | Plasmacytoma, extramedullary | 21 |
 | 9742/3 | Mast cell leukemia | 1 |
 | 9750/3 | Malignant histiocytosis | 1 |
 | 9751/1 | Langerhans cell histiocytosis, NOS | 7 |
 | 9761/3 | Waldenstrom macroglobulinemia | 1 |
 | 9765/1 | Monoclonal gammopathy | 7 |
 | 9823/3 | B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma | 646 |
 | 9826/3 | Acute lymphoblastic leukemia, mature B-cell type | 31 |
 | 9827/3 | Adult T-cell leukemia/lymphoma [HTLV-1 pos.] | 82 |
 | 9833/3 | Prolymphocytic leukemia, B-cell type | 6 |
 | 9834/3 | Prolymphocytic leukemia, T-cell type | 42 |
 | 9835/3 | Acute lymphoblastic leukemia, NOS | 272 |
 | 9836/3 | Precursor B-cell lymphoblastic leukemia | 280 |
 | 9837/3 | Precursor T-cell lymphoblastic leukemia | 108 |
 | 9840/3 | Acute erythroid leukemia [FAB M6] | 7 |
 | 9860/3 | Myeloid leukemia, NOS | 1 |
 | 9861/3 | Acute myeloid leukemia, NOS | 247 |
 | 9866/3 | Acute promyelocytic leukemia [FAB type M3] | 6 |
 | 9867/3 | Acute myelomonocytic leukemia [FAB type M4] | 31 |
 | 9871/3 | Acute myelomonocytic leukemia with abnormal marrow eosinophils [FAB M4Eo] | 3 |
 | 9872/3 | Acute myeloblastic leukemia with minimal differentiation [FAB type M0] | 3 |
 | 9873/3 | Acute myeloblastic leukemia without maturation [FAB type M1] | 18 |
 | 9874/3 | Acute myeloblastic leukemia with maturation [FAB M2] | 27 |
 | 9875/3 | Chronic myelogenous leukemia | 20 |
 | 9891/3 | Acute monoblastic leukemia without differentiation [FAB M5a] | 20 |
 | 9895/3 | Acute myeloid leukemia with prior myelodysplastic syndrome | 6 |
 | 9910/3 | Acute megakaryoblastic leukemia [FAB M7] | 13 |
 | 9920/3 | Therapy-related acute myeloid leukemia, NOS | 1 |
 | 9940/3 | Hairy cell leukemia | 36 |
 | 9945/3 | Chronic myelomonocytic leukemia, NOS | 3 |
 | 9948/3 | Aggressive NK-cell leukemia | 6 |
 | 9950/3 | Polycythemia vera | 29 |
 | 9961/3 | Chronic idiopathic myelofibrosis | 26 |
 | 9962/3 | Essential thrombocythemia | 8 |
 | 9963/3 | Chronic neutrophilic leukemia | 1 |
 | 9980/3 | Refractory anemia, NOS | 26 |
 | 9982/3 | Refractory anemia with ringed sideroblasts [RARS] | 12 |
 | 9983/3 | Refractory anemia with excess blasts [RAEB] | 21 |
 | 9984/3 | Refractory anemia with excess blasts in transformation [RAEBT] | 26 |
 | 9985/3 | Refractory cytopenia with multilineage dysplasia | 2 |
 | 9986/3 | Myelodysplastic syndrome with 5q- syndrome | 3 |
 | 9989/3 | Myelodysplastic syndrome, NOS | 3 |